NCT06962397 Effectiveness of Active Exploration of Simulated Textures for Sensorimotor Recovery
| NCT ID | NCT06962397 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2024-10-08 |
| Primary Completion | 2025-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2024-10-08 with a primary completion date of 2025-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Parallel-group, single-blinded controlled clinical trial. The study includes people aged 18-80 years, more than one month after stroke, with confirmed diagnosis, MoCA ≥ 20, and Barthel Index ≥ 3. The control group receives standard rehabilitation. The experimental group also receives active sensory training with programmable electrical stimulation to simulate virtual textures. Sensory function was assessed before and after the training using standard tests, including Fugl-Meyer, ARAT, 9HPT, and monofilament testing.
Eligibility Criteria
Inclusion Criteria: * Episode of stroke confirmed by neuroimaging * More than one month post-stroke * Montreal Cognitive Assessment (MoCA) score ≥ 20 * Barthel Index score ≥ 3 * Ability to understand and follow instructions * Informed consent for participation and data collection * Age 18-80 years Exclusion Criteria: * Presence of depressive symptoms (HADS-Depression \> 11) * Upper limb paresis score below 35 on the Fugl-Meyer scale * Sensory impairment score below 3 or above 10 on the Fugl-Meyer scale
Contact & Investigator
Galina Ivanova, Professor
STUDY CHAIR
Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health
Frequently Asked Questions
Who can join the NCT06962397 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06962397 currently recruiting?
Yes, NCT06962397 is actively recruiting participants. Contact the research team at mariavolodina@yandex.ru for enrollment information.
Where is the NCT06962397 trial being conducted?
This trial is being conducted at Moscow, Russia.
Who is sponsoring the NCT06962397 clinical trial?
NCT06962397 is sponsored by Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health. The principal investigator is Galina Ivanova, Professor at Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.